Expression and significance of IPO7 in hepatocellular carcinoma based on bioinformatics analysis

张维志,刘连新

DOI: https://doi.org/10.3877/cma.j.issn.2095-3232.2023.06.019

2023-01-01

Abstract:Objective:To investigate the expression and clinical significance of importin 7 (IPO7) in hepatocellular carcinoma (HCC) based on bioinformatics analysis.Methods:The expression level of IPO7 in HCC was analyzed by TIMER 2.0, UALCAN and CPTAC databases, and multiple gene chips were downloaded from GEO database for further verification. The correlation between IPO7 expression and clinicopathological characteristics of HCC patients was analyzed based on GEPIA2 and UALCAN databases. Binary Logistic regression was conducted using TCGA HCC data to further analyze and validate the correlation between IPO7 expression and clinicopathological characteristics of HCC patients. Based on GEPIA2 and Kaplan-Meier Plotter databases, the effect of IPO7 expression on clinical prognosis of HCC patients was analyzed. Prognostic value of IPO7 was further evaluated by Cox regression model and nomogram was constructed to evaluate clinical prognosis of HCC. Based on LinkedOmics database, the co-expression genes of IPO7 in HCC were analyzed. GO function and KEGG pathway enrichment analyses were performed to predict biological function. Protein-protein interaction (PPI) network was further constructed through STRING database. Based on TIMER 2.0 database, the relationship between IPO7 expression and immune infiltration level of HCC was analyzed. The expression level of IPO7 between two groups was compared by t test orrank-sum test. The relationship between clinical staging and IPO7 expression was assessed by One Way ANOVA. Survival analysis was conducted by Kaplan-Meier method and Log-rank test. The prognostic value of IPO7 was determined by Cox proportional hazard regression model.Results:UALCAN database analysis showed that the median expression level of IPO7 mRNA in HCC tissues was 16.9(10.7, 23.7), significantly higher than 11.9(10.3, 14.1) in normal liver tissues (P<0.05). Multiple gene chips downloaded from GEO database further validated that relative expression level of IPO7 mRNA in HCC tissues was significantly higher compared with that in normal liver tissues. CPTAC database further verified that the expression of IPO7 protein was 0(-0.778, 0.654) in HCC, significantly higher than -1.582(-2.367, -0.559) in normal liver tissues (P<0.05). GEPIA2 database showed that the expression level of IPO7 was gradually up-regulated with the increase of stages of HCC (F=4.83, P<0.05). UALCAN database indicated that the expression of IPO7 mRNA was correlated with AJCC clinical staging, histological grading and TP53 mutation (P<0.05). GEPIA2 database analysis revealed that the overall survival (OS) and disease-free survival (DFS) were shorter in the high IPO7 expression group (HR=1.700, 1.400; P<0.05). Multivariate Cox analysis showed that the expression of IPO7 mRNA was an independent risk factor for poor prognosis in HCC patients (HR=1.675, P<0.05). KEGG pathway enrichment and protein-protein interaction (PPI) network analyses with STRING database indicated that IPO7 protein mainly participated in the transfer of protein to the nucleus, cell cycle regulation, transcription regulation, mitotic spindle regulation, coordination of mitosis and rRNA processing, etc.TIMER 2.0 database analysis showed that the expression level of IPO7 was positively correlated with the infiltration levels of CD8+ T cells, CD4+ T cells, B cells, macrophages, neutrophils and dendritic cells (r=0.191, 0.364, 0.270, 0.450, 0.485, 0.310; P<0.05).Conclusions:IPO7 can be used as a biomarker for poor prognosis and potential therapeutic target for HCC, which regulates the incidence and development of HCC probably by regulating nucleo-cytoplasmic transport, affecting cell cycle and immune cell infiltration-related signaling pathways.